Undescribed Phyllocladane-Type Diterpenoids from <i>Callicarpa giraldii</i> Hesse ex Rehd. and Their Anti-Neuroinflammatory Activity

<i>Callicarpa giraldii</i> Hesse ex Rehd. is an endemic plant in China and has long been used as a traditional medicine in several provinces. Although the plant has been reported to contain flavonoids, triterpenes, and alkaloids, this study represents the first report of the isolation of...

Full description

Saved in:
Bibliographic Details
Main Authors: Xu Liang, Qi Gong, Yuting Xu, Jiaxing Mu, Chunping Tang, Bintao Hu, Changqiang Ke, Sheng Yao, Haiyan Zhang, Yang Ye
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/30/7/1553
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:<i>Callicarpa giraldii</i> Hesse ex Rehd. is an endemic plant in China and has long been used as a traditional medicine in several provinces. Although the plant has been reported to contain flavonoids, triterpenes, and alkaloids, this study represents the first report of the isolation of phyllocladane-type diterpenoids, a relatively rare class of compounds. In this study, 18 new phyllocladane-type diterpenoids (<b>7</b>–<b>24</b>) were isolated and structurally elucidated, including eight uncommon 3,4-<i>seco</i> phyllocladane-type diterpenoids (<b>15</b>–<b>22</b>) and two unusual phyllocladane-type diterpene dimers (<b>23</b>–<b>24</b>), along with six known analogues (<b>1</b>–<b>6</b>). Their structures were elucidated by a comprehensive analysis of 1D and 2D NMR, IR, and HRESIMS data. The absolute configurations were determined by single crystal X-ray diffraction experiments, DFT NMR calculations, and TDDFT ECD calculations. Based on the obtained and reported spectroscopic data, we refined a rule to distinguish phyllocladane-type diterpenoids from their diastereomeric <i>ent</i>-kaurane-type compounds. Additionally, the isolated compounds were evaluated for their in vitro anti-neuroinflammatory activity against lipopolysaccharide (LPS)-induced inflammation in BV-2 microglial cells. Compounds <b>5</b>, <b>10</b>, <b>13</b>, <b>18</b>, <b>19</b>, and <b>20</b> showed moderate inhibitory activity at the concentration of 20 μM, with compounds <b>5</b> and <b>13</b> markedly reducing the mRNA levels of the pro-inflammatory cytokines IL-1<i>β</i>, IL-6, and TNF-<i>α</i> at this concentration.
ISSN:1420-3049